Cargando…

Clinical trials on drug repositioning for COVID-19 treatment

The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genus Betacoronavirus, that is dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosa, Sandro G. Viveiros, Santos, Wilson C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Organización Panamericana de la Salud 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105280/ https://www.ncbi.nlm.nih.gov/pubmed/32256547 http://dx.doi.org/10.26633/RPSP.2020.40

Ejemplares similares

MeSHDD: Literature-based drug-drug similarity for drug repositioning
por: Brown, Adam S, et al.
Publicado: (2017)

Drug repositioning is an alternative for the treatment of coronavirus COVID-19
por: Serafin, Marissa B., et al.
Publicado: (2020)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

COVID-19 trial graph: a linked graph for COVID-19 clinical trials
por: Du, Jingcheng, et al.
Publicado: (2021)

Misalignment between COVID-19 hotspots and clinical trial sites
por: Franks, Lauren, et al.
Publicado: (2021)

COVID-19: Analysis of Drug Repositioning Practice
por: Savosina, P. I., et al.
Publicado: (2021)

Evaluation of the Prescribed Drugs to Elderly in a Tertiary Healthcare Center for Possible Drug Interactions with Investigational Drugs for COVID-19 Treatment
por: Keche, Yogendra, et al.
Publicado: (2021)

Impact of COVID-19 on management of clinical trials and the potential mitigating strategies
por: Sarve, Parag, et al.
Publicado: (2023)

Clinical trials of COVID-19 vaccine development: a global overview
por: Lopes, João Victor Antunes, et al.
Publicado: (2023)

Repositioned Drugs for COVID-19—the Impact on Multiple Organs
por: Chan, Christina, et al.
Publicado: (2021)

The COVID-19 Trial Finder
por: Sun, Yingcheng, et al.
Publicado: (2020)

Machine learning and network medicine approaches for drug repositioning for COVID-19
por: Santos, Suzana de Siqueira, et al.
Publicado: (2021)

Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19?
por: de Carvalho, Fernanda Oliveira, et al.
Publicado: (2021)

From clinical trials to clinical practice: How long are drugs tested and then used by patients?
por: Yuan, Chi, et al.
Publicado: (2021)

Clinical trials for vaccine development in registry of Korea Food and Drug Administration
por: Kang, Seog-Youn
Publicado: (2013)

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 Treatment
por: Tsai, Ming-Ju, et al.
Publicado: (2023)

Development of a Coronavirus Disease 2019 (COVID-19) Application Ontology for the Accrual to Clinical Trials (ACT) network
por: Visweswaran, Shyam, et al.
Publicado: (2021)

Ivermectin: Potential Role as Repurposed Drug for COVID-19
por: Dixit, Alok, et al.
Publicado: (2020)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

The pulmonary route as a way to drug repositioning in COVID-19 therapy
por: Sarcinelli, Michelle Alvares, et al.
Publicado: (2021)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

A survey to assess the impact of the COVID-19 pandemic and the resultant lockdown measures on the ongoing clinical trials in India
por: Gupta, Jayanti, et al.
Publicado: (2021)

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
por: Oliver, Josidel Conceição, et al.
Publicado: (2022)

Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
por: Vaz, Elisa Souza, et al.
Publicado: (2023)

Poor Outcome of Intestinal Ischemic Manifestations of COVID-19
por: Norsa, Lorenzo, et al.
Publicado: (2020)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Retroversion of the Impregnated Uterus and Spontaneous Reposition
por: Gay, C. C. F.
Publicado: (1868)

Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials
por: Yuh, Tiffany, et al.
Publicado: (2022)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)

Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19
por: Du, Mulong, et al.
Publicado: (2020)

Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy
por: Sardu, Celestino, et al.
Publicado: (2020)

Continuous positive airway pressure (CPAP) as a ceiling of care treatment for hypoxemic respiratory failure due to COVID-19
por: Bradley, Patrick, et al.
Publicado: (2021)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
por: Won, Jung-Hyun, et al.
Publicado: (2020)

Comparison of Computerized Prescription Support Systems in COVID-19 Patients: INTERCheck and Drug-PIN
por: Martocchia, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mp5m1it37as2f5f568in4uvoqr